Trials / Completed
CompletedNCT00394667
Effect of Tesofensine on Weight Reduction in Patients With Obesity.
Effect of Tesofensine on Weight Reduction in Patients With Obesity. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- NeuroSearch A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: To evaluate the efficacy on weight reduction, metabolic parameters and safety of tesofensine versus placebo in obese patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tesofensine |
Timeline
- Start date
- 2006-09-01
- Completion
- 2007-09-01
- First posted
- 2006-11-01
- Last updated
- 2013-04-22
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00394667. Inclusion in this directory is not an endorsement.